Integrated analysis reveals the potential of cluster of differentiation 86 as a key biomarker in high-grade glioma
Figure 3.The Kaplan-Meier survival analysis of CD86 in different subgroups among HGG patients. Abbreviation: HR, Hazard ratio; CI, confidence interval.